頸動脈小体腫瘍の診断と治療

研究成果: Article査読

抄録

With the widespread application of genetic testing in recent years, the pathogenesis of carotid body tumors has been clarified. At present, tumor resection is the only curative treatment, with the high risk of perioperative complications, such as intraoperative hemorrhage, inferior cerebral nerve dysfunction, and cerebral infarction. A multidisciplinary team approach is essential for planning safe surgical resection. In addition, treatment options are limited for cases with unresectable disease, such as those with invasion of adjacent structures and/or distant metastasis. New treatment methods are developing. In the near future, new therapies targeting factors contributing to tumor development, such as SDHx, and tumor progression are expected to be developed.

寄稿の翻訳タイトルDiagnosis and Management of Carotid Body Tumors
本文言語Japanese
ページ(範囲)259-264
ページ数6
ジャーナルPractica Oto-Rhino-Laryngologica
115
4
DOI
出版ステータスPublished - 2022

Keywords

  • carotid body tumor
  • multidisciplinary team approach
  • SDHB variant
  • SDHD variant

ASJC Scopus subject areas

  • 耳鼻咽喉科学

フィンガープリント

「頸動脈小体腫瘍の診断と治療」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル